Shed syndecan-2 inhibits angiogenesis

McKay, TR, De Rossi, G, Evans, AR, Kay, E, Woodfin, A, Nourshargh, S and Whiteford, JR (2014) Shed syndecan-2 inhibits angiogenesis. Journal of Cell Science, 127. ISSN 1477-9137

Preview

Available under License Creative Commons Attribution. Download (4MB) | Preview

Abstract

Angiogenesis is essential for the development of a normal vasculature, tissue repair and reproduction, and also has roles in the progression of diseases such as cancer and rheumatoid arthritis. The heparan sulphate proteoglycan syndecan-2 is expressed on mesenchymal cells in the vasculature and, like the other members of its family, can be shed from the cell surface resulting in the release of its extracellular core protein. The purpose of this study was to establish whether shed syndecan-2 affects angiogenesis. We demonstrate that shed syndecan-2 regulates angiogenesis by inhibiting endothelial cell migration in human and rodent models and, as a result, reduces tumour growth. Furthermore, our findings show that these effects are mediated by the protein tyrosine phosphatase receptor CD148 (also known as PTPRJ) and this interaction corresponds with a decrease in active beta1 integrin. Collectively, these data demonstrate an unexplored pathway for the regulation of new blood vessel formation and identify syndecan-2 as a therapeutic target in pathologies characterised by angiogenesis.